A weekly round-up of the
latest coverage in psychedelics.
Receive the free weekly digest straight to your inbox every week
By signing up, you agree to our privacy policy. You can unsubscribe at any time.
September 7 – 13, 2026
This week's feed, sponsored by
Monash University’s Clinical Psychedelic Lab will convene the inaugural Conference for Asia-Pacific Psychedelic Science (CAPS27) in Melbourne, Australia on 24–26 February 2027. Abstract submissions close in less than one week (18 September 2026). Accepted presenters can apply for a limited number of travel grants.
Apply here
Davis, Farchione and Colleagues Present FDA’s Psychedelic Drug Framework in NEJM
Psychedelic Alpha ↗
August 31 – September 6, 2026
A Note From the Editor
It’s been another relatively quiet week in the psychedelics field.
Earlier this week, we published Psychedelic Bulletin 230, which looked at ARPA-H’s ibogaine funding opportunity, among other things.
We also took that break in the news cycle to update our Library entry on Psychedelic REMS, which provides an overview of the subject and a look at what REMS for psychedelic medicines could look like.
We are now gearing up for various hearings and meetings in Washington, DC in the coming weeks, starting with FDA’s Public Hearing on Monday 14th of September. That’s followed by an ARPA-H Proposers Day and more.
Below, you will find your Psychedelic News Feed, a one-stop digest for the latest coverage of psychedelic business, policy, research and beyond.
Josh Hardman
Founder & Editor
As psychedelics near FDA approval, donors rush to fund the next frontier
Chronicle of Philanthropy ↗
Pα+
An insider’s guide to the business,
policy and science of psychedelics.
Basic
Free subscribers receive a weekly round-up of news on psychedelics, as well as the occasional article.
Receive regular bulletins, articles, interviews with insiders and quick-take analysis of major stories and developments.
Teams
Teams, groups and corporate pricing plans are available, please get in touch via email to learn more.
Benefits
Front-row access to the psychedelics space: breaking bulletins, in-depth articles, insider interviews and sharp analysis of the moments that matter—from major trial results and funding rounds to policy shifts shaping the future. Plus, full access to our complete archive and Library.
Learn More| Free | ||
|---|---|---|
| Weekly Psychedelic News Feed | ||
| Occasional Articles & Free Resources | ||
| Psychedelic Bulletins (In-Depth Briefings, Multiple per Month) | ||
| Quick-Take Analysis of Major Developments | ||
| In-Depth Articles & Deep Dives | ||
| Exclusive Interviews with Insiders & KOLs | ||
| Quarterly Video Briefings | ||
| Exclusive Tools & Data Resources | ||
| Library of Primers & Explainers | ||
| Exclusive audio dispatches from our Editor | ||
|
Subscribe Now |
||